Evidence map›Paper›PMID 32487168›Full record

ArticleBMC nephrology2020

Acute kidney disease and acute kidney injury biomarkers in coronary care unit patients.

Yih-Ting Chen, Chang-Chyi Jenq, Cheng-Kai Hsu, Yi-Ching Yu, Chih-Hsiang Chang, Pei-Chun Fan, Heng-Chih Pan, I-Wen Wu, Wen-Jin Cherng, Yung-Chang Chen

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. IL-18 and IL-18BP: A Unique Dyad in Health and Disease.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yih-Ting ChenDepartment of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan.
Chang-Chyi JenqKidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Cheng-Kai HsuDepartment of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan.
Yi-Ching YuDepartment of Neurology, Chang Gung Memorial Hospital, Keelung, Taiwan.
Chih-Hsiang ChangKidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Pei-Chun FanKidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Heng-Chih PanDepartment of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan.
I-Wen WuDepartment of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan.
Wen-Jin CherngDepartment of Cardiology, Chang Gung Memorial Hospital, Linkou, Taiwan.
Yung-Chang ChenDepartment of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan. cyc2356@adm.cgmh.org.tw.
Keelung Chang Gung Memorial Hospital · TWChang Gung Memorial Hospital · TWChang Gung University · TW

Funding

Chang Gung Medical Research Fund CLRPG2H0041Ministry of Science and Technology, Taiwan MOST107-2314-B-182A-019 -MY3
6 · The paper itself

Abstract

backgroundAcute kidney disease (AKD) describes acute or subacute damage and/or loss of kidney function for a duration of between 7 and 90 days after exposure to an acute kidney injury (AKI) initiating event. This study investigated the predictive ability of AKI biomarkers in predicting AKD in coronary care unit (CCU) patients.

methodsA total of 269 (mean age: 64 years; 202 (75%) men and 67 (25%) women) patients admitted to the CCU of a tertiary care teaching hospital from November 2009 to September 2014 were enrolled. Information considered necessary to evaluate 31 demographic, clinical and laboratory variables (including AKI biomarkers) was prospectively recorded on the first day of CCU admission for post hoc analysis as predictors of AKD. Blood and urinary samples of the enrolled patients were tested for neutrophil gelatinase-associated lipocalin (NGAL), cystatin C (CysC) and interleukin-18 (IL-18).

resultsThe overall hospital mortality rate was 4.8%. Of the 269 patients, 128 (47.6%) had AKD. Multivariate logistic regression analysis revealed that age, hemoglobin, ejection fraction and serum IL-18 were independent predictors of AKD. Cumulative survival rates at 5 years of follow-up after hospital discharge differed significantly (p < 0.001) between subgroups of patients diagnosed with AKD (stage 0A, 0C, 1, 2 and 3). The overall 5-year survival rate was 81.8% (220/269). Multivariate Cox proportional hazard analysis revealed that urine NGAL, body weight and hemoglobin level were independent risk factors for 5-year mortality.

conclusionsThis investigation confirmed that AKI biomarkers can predict AKD in CCU patients. Age, hemoglobin, ejection fraction and serum IL-18 were independently associated with developing AKD in the CCU patients, and urine NGAL, body weight and hemoglobin level could predict 5-year survival in these patients.

Indexed as

Acute DiseaseAcute Kidney InjuryAgedAge FactorsBiomarkersBody WeightClofibrateCoronary Care UnitsCystatin CDrug CombinationsFemaleFollow-Up StudiesHemoglobinsHospital MortalityHumansInterleukin-18BiomarkersClofibrateCystatin CDrug CombinationsHemoglobinsIL18 protein, humanInterleukin-18N 041PhosphatidylcholinesAKDAKIBiomarker and CKDCCU

Identifiers

PMID32487168
PMCPMC7268535
OpenAlexW3032447687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.